Evaluation of Risk Factors related to Ovarian Involvement in Endometrial Cancer Patients: A Retrospective Study
Risk Factors related to Ovarian Involvement in Endometrial Cancer
Keywords:
Endometrial Cancer; Ovarian Metastasis; Risk Factors; Cancer; Case-control StudyAbstract
Background: Endometrial cancer (EC) is a cancer that occurs in women. This study aimed to determine the risk factors of Ovarian involvement (OI) in patients with EC and define the risk of developing an associated malignancy during follow-up after EC treatment. Materials and Methods: This retrospective study (n=280) was conducted to determine the risk factors of OI following EC in female patients with a definitive diagnosis of uterine cancer admitted to Imam Khomeini Hospital in Tehran over the preceding 15 years, between 2010 and 2024. We evaluated the roles of risk factors for OI, such as age, histological subtype, tumor grade, myometrial infiltration, tumor diameter, cervical infiltration, lympho vascular space invasion (LVSI), and positive peritoneal cytology for malignancy (P.P.C). Results: The results showed that there was a relationship between the risk factors of myometer, LVSI, cervix, serous, tube, intra-abdominal, complaint, lymph node and omentum between the two groups with and without OI (P>0.05). Based on Univariate and Multiple Analysis, the results showed that Omentum Involvement, P.P.C and Serous Carcinoma were related to OI. Also, based on multivariate logistic regression The results confirmed that the following predictors were correlated with OI: P.P.C (OR=8.54, 95% CI=1.52_47.88, P-value=0.015), omentum involvement (OR=10.82, 95% CI=2.21_52.82, P-value=0.03), and serous carcinoma (OR=4.41, 95% CI=1.44_13.53, P-value 0.009). Conclusion: Myometer, LVSI, cervix, serous, tube, intra-abdominal, complaint, lymph node and omentum factors were related to OI. Evaluation of risk factors plays an important role in the management of EC patients who are exposed to ovarian metastasis, therefore, the diagnosis of risk factors can be helpful in treatment strategies.
References
Sung H, et al. "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" . CA Cancer J Clin. 2021; 71(3): 209-249.
https://doi.org/10.3322/caac.21660
PMid:33538338
Sadeghi j, et al. "Impact of analgesics on the risk of ovarian cancer; a systematic review and meta-analysis of cohort and case-control studies" . Immunopathol Persa. 2023;x(x) :e40572.
https://doi.org/10.34172/ipp.2023.40572
Shen L, et al. "A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1/G2 endometrioid endometrial cancer,". Gynecol Oncol. 2020;159(2):402-408, .
https://doi.org/10.1016/j.ygyno.2020.08.017
PMid:32847677
Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai e. "Endometrial cancer,". Lancet. 2016 ;387(10023):1094-1108.
https://doi.org/10.1016/S0140-6736(15)00130-0
PMid:26354523
Mirghaderi p, Gholamshahi h, Jahromi a, Iranmehr a, Dabbagh-Ohadi ma, Eshraghi n. "Unexpected positive culture (UPC) in adults revision spine surgery: a systematic review and meta-analysis of incidence, risk factors, and management,". Eur Spine J. 2024; :1-9.
https://doi.org/10.1007/s00586-024-08229-2
PMid:38573385
Baker j, Obermair A, Gebski v, Janda m. "Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature,". Gynecol Oncol. 2012;125(1):263-270 .
https://doi.org/10.1016/j.ygyno.2011.11.043
PMid:22196499
Guo jz, Wu qj, Liu fh,Gao c,Gong tt, Li g. "Review of Mendelian randomization studies on endometrial cancer,". Front Endocrinol (Lausanne). 2022;13:783150.
https://doi.org/10.3389/fendo.2022.783150
PMid:35615721 PMCid:PMC9124776
Wen kc, et al. "The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma,". Gynecol Oncol. 2018;148(2): 383-392.
https://doi.org/10.1016/j.ygyno.2017.11.033
PMid:29208367
Wang PH, Wen KC, Yen MS. Challenges in the management of recurrent endometrial cancer. J Chin Med Assoc. 2016 Apr;79(4):171-3.
https://doi.org/10.1016/j.jcma.2015.11.005
PMid:26775603
Shayan s, Osgoei lt, Jouni fj. "Effect of capecitabine and melatonin on HER2+ (SK-BR-3) and HER2-(MCF7) human breast cancer cell lines," . Trop J Pharm Res. 2023; 22(7):1387-1393.
https://doi.org/10.4314/tjpr.v22i7.5
Liang x, Zeng h, Chen s, Jiang m, Liu s, Fan j. "Ovarian metastasis risk factors in endometrial carcinoma: a systematic review and meta-analysis,". Eur J Obstet Gynecol Reprod Biol. 2021;267:245-255.
https://doi.org/10.1016/j.ejogrb.2021.11.016
PMid:34837854
Sharami sh, et al. "The association of sociodemographic factors and history of chronic diseases on menopausal symptoms: A cross‐sectional study,". Health Sci Rep. 2024; 7(5):e2103.
https://doi.org/10.1002/hsr2.2103
PMid:38715722 PMCid:PMC11074517
Hantoushzadeh s, et al. "Diagnostic value of neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratio to predict recurrent pregnancy loss and abortion; a systematic review and meta‐analysis,". Immun Inflamm Dis. 2024; 12(3):e1210.
https://doi.org/10.1002/iid3.1210
PMid:38506423 PMCid:PMC10953208
Ignatov t, Eggemann h, Burger e, Ortmann o, Costa sd, Ignatov a. "Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival,". J Cancer Res Clin Oncol. 2018;144:1103-1107.
https://doi.org/10.1007/s00432-018-2628-2
PMid:29541859
Rezaei m, et al. "Role of artificial intelligence in the diagnosis and treatment of diseases,". Kindle. 2023; 3(1): 1-160.
Hedayat p, Derakhshan m, Ghasemi r. "The frequency of SATB2 and CDX2 expression in metastatic mucinous tumors of ovarian and colonic origin,". Immunopathol Persa. 2024;10(2):e40620-e40620.
https://doi.org/10.34172/ipp.2024.40620
Ashrafganjoei t, Bahman a, NoeiTeymoordash s, Aminimoghaddam s, Ebrahimi a, Talayeh m. "The Incidence of Ovarian Involvement in Endometrioid Endometrial Adenocarcinoma: A Retrospective Analysis,". J Obstet Gynecol Cancer Res. 2021; 6(3): 105-109.
https://doi.org/10.30699/jogcr.6.3.105
Baiocchi g, et al. "Adnexal Involvement in Endometrial Cancer: Prognostic Factors and Implications for Ovarian Preservation,". (in eng), Ann Surg Oncol. 2020; 27(8): 2822-2826.
https://doi.org/10.1245/s10434-020-08261-8
PMid:32080810
Nofech-Mozes s, et al. "Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases,". (in eng) Am J Clin Pathol. 2008; 129(1): 110-4.
https://doi.org/10.1309/UDYANQ6XTK6UUTXQ
PMid:18089496
Ignatov t, Eggemann h, Burger e, Ortmann o, Costa sd, Ignatov a. "Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival,". (in eng), J Cancer Res Clin Oncol. 2018; 6: 1103-1107.
https://doi.org/10.1007/s00432-018-2628-2
PMid:29541859
Pan z, Wang x, Zhang x, Chen x, Xie x. "Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma,". J Obstet Gynecol Cancer Res. 2011;37(4): 352-358.
https://doi.org/10.1111/j.1447-0756.2010.01354.x
PMid:21314805
Li ly, Zeng sy, Wan l, Ao mh. "Study of the risk factors for ovarian metastasis in patients with endometrial carcinoma,". Zhonghua fu Chan ke za zhi. 2008; 43(5): 352-355.
Matoba y, et al. "Characteristics and clinicopathological features of patients with ovarian metastasis of endometrial cancer: a retrospective study,". (in eng), J Obstet Gynaecol. 2022; 42(6):2456-2462.
https://doi.org/10.1080/01443615.2022.2071148
PMid:35653769
Li j, et al. "Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients,". Eur J Obstet Gynecol Reprod Biol. 2018;222:151-154.
https://doi.org/10.1016/j.ejogrb.2018.01.030
PMid:29408747
Li q ,Zhang x. "Prediction of high‐risk factors for ovarian metastasis in patients with endometrial cancer: A large‐sample retrospective case-control study,". Int J Gynaecol Obstet. 2023; 161(1): 144-150.
https://doi.org/10.1002/ijgo.14606
PMid:36453189
Xu j,Chen c, Xiong j, Wang h, Linghu h. "Predictive Value of Serum Cytokeratin 19 Level for the Feasibility of Conserving Ovaries in Endometrial Cancer,". (in eng), Front Med (Lausanne). 2021;8:670109.
https://doi.org/10.3389/fmed.2021.670109
PMid:34422851 PMCid:PMC8374735
Li q, Zhang x. "Prediction of high-risk factors for ovarian metastasis in patients with endometrial cancer: A large-sample retrospective case-control study,". (in eng), Int J Gynaecol Obstet. 2023; 161(1):144-150.
https://doi.org/10.1002/ijgo.14606
PMid:36453189
Zhao q, Li y, Wang t. "Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma," . (in eng), Medicine (Baltimore). 2023; 102(41): e35439.
https://doi.org/10.1097/MD.0000000000035439
PMid:37832099 PMCid:PMC10578755
Liane s, Deligdisch m, Angelica M. "Hormonal Pathology of the Endometrium and Endometrial Carcinoma,". J Surgical Endocrinol. 2022;13(3):285-94.
https://doi.org/10.1038/modpathol.3880050
PMid:10757339
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Galen Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
